{"id":"https://genegraph.clinicalgenome.org/r/64efb154-4f69-46e7-8ca3-9eecf59b2923v1.1","type":"EvidenceStrengthAssertion","dc:description":"HYCC1 was first reported in association with autosomal hypomyelinating leukodystrophy 5 (OMIM:610532) in 2006 (Zara et al., PMID: 16951682). HYCC1 codes for the Hyccin protein, which is involved in the PI4KA lipid kinase complex and is used for synthesis of phosphatidylinositol 4-phosphate (PI4P). Hyccin is essential for myelin development and growth. Hypomyelinating leukodystrophy 5 is characterized by bilateral congenital cataracts, developmental delay, mild-to-moderate intellectual disability, pyramidal signs and spasticity, cerebellar signs/ataxia, seizures, and scoliosis. MRI findings include hypomyelination and abnormalities of the brainstem pyramidal tract. (PMID: 21911699). \n\nEight variants (2 splice-site, 2 missense, 1 intragenic deletion, 3 frameshift) from 4 publications (PMID: 16951682, 17928815, 23998934, 21911699) have been included in this curation. Segregation data from four families was also scored as genetic evidence in this curation (PMID: 16951682, 17928815). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. Of note, the c.51+1G>A variant and c.414+1G>T variant have been reported in multiple unrelated families as potential founder variants in Mediterranean populations (PMID: 16951682, 21911699, 34192786). The mechanism of pathogenicity for HYCC1 is loss of function.\n\nThis gene-disease relationship is also supported by experimental evidence. Gazzerro et al. showed that the Hyccin protein is expressed in relevant disease tissues in mice (PMID: 22461884). Zhang et al. demonstrated that Hyccin knockdown Drosophila demonstrated overlapping phenotype with human disease, which was rescued by the expression of the human HYCC1 gene (PMID: 34894559). \n\nIn summary, there is definitive evidence supporting the relationship between HYCC1 and hypomyelinating leukodystrophy 5 (MONDO: 0012514), also known as HYCC1-related hypomyelinating leukodystrophy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Leukodystrophy GCEP on February 12, 2025 (SOP version 11). \n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/64efb154-4f69-46e7-8ca3-9eecf59b2923","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2025-03-13T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10107","date":"2025-03-13T17:13:44.186Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7622b8c-ff2a-4141-ae8a-4359370737b5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7622b8c-ff2a-4141-ae8a-4359370737b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F2_P5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"allele":{"id":"https://genegraph.clinicalgenome.org/r/08eebf58-9ea8-4f96-946f-e3d5967662e5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032581.4(HYCC1):c.51+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339886"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000519","obo:HP_0033044","obo:HP_0002650","obo:HP_0001249","obo:HP_0007256","obo:HP_0001250","obo:HP_0001317"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/62ee08ab-e498-4a6a-891d-e8f58f51154b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","allele":{"id":"https://genegraph.clinicalgenome.org/r/08eebf58-9ea8-4f96-946f-e3d5967662e5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/62ee08ab-e498-4a6a-891d-e8f58f51154b","type":"EvidenceLine","dc:description":"Founder/Recurrent variant. per GCEP decision, not scoring multiple times.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62ee08ab-e498-4a6a-891d-e8f58f51154b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/26accb24-05e6-4702-81d2-e4e57f804ffb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26accb24-05e6-4702-81d2-e4e57f804ffb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17928815","rdfs:label":"Ugur_504","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1fcfb4a3-3c6f-4fae-9a7f-ae37ea5e5275","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000007.14:g.22960901_22964984del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342416"}},"firstTestingMethod":"PCR","phenotypeFreeText":"Diffuse and symmetrical deep white matter changes as shown in T2-weighted image hyperintensities and T1-weighted image hypointensities were seen in supratentorial structures. Paraventricular white matter comprising the temporal horns, internal and external capsules, corona radiata and centrum semiovale were involved symmetrically in both the anterior and posterior parts of the cerebral hemispheres.","phenotypes":["obo:HP_0001249","obo:HP_0001250","obo:HP_0000519","obo:HP_0002505"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/154dfd48-64e5-41d9-a47f-70104ad2586f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17928815","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fcfb4a3-3c6f-4fae-9a7f-ae37ea5e5275"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/154dfd48-64e5-41d9-a47f-70104ad2586f","type":"EvidenceLine","dc:description":"Per ClinGen NDWG scoring guidelines, proband scores are capped at 2","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/154dfd48-64e5-41d9-a47f-70104ad2586f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/17cfa125-61aa-450c-8b8a-b34f986ce089_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17cfa125-61aa-450c-8b8a-b34f986ce089","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F3_P6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/08eebf58-9ea8-4f96-946f-e3d5967662e5"},"firstTestingMethod":"PCR","phenotypeFreeText":"Higher signal intensity in hemispheric white matter. Decreased number of myelinated fibers in sural nerve biopsy. Several large axons lacking a myelin sheath, or having a thin myelin sheath. Occasionally, small onion bulbs formed by Schwann cell processes\nwrapping around thinly myelinated axons are observed (arrows), indicative of\nremyelination.","phenotypes":["obo:HP_0007256","obo:HP_0033044","obo:HP_0001317","obo:HP_0002650","obo:HP_0009830","obo:HP_0007305","obo:HP_0001249","obo:HP_0000519"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5309dfd7-96d7-4ee3-a30d-89d10cda95c9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","allele":{"id":"https://genegraph.clinicalgenome.org/r/08eebf58-9ea8-4f96-946f-e3d5967662e5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/5309dfd7-96d7-4ee3-a30d-89d10cda95c9","type":"EvidenceLine","dc:description":"Per ClinGen NDWG scoring guidelines, proband scores are capped at 2","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5309dfd7-96d7-4ee3-a30d-89d10cda95c9_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9f70689d-a6f0-45a8-837f-52b267417bd4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f70689d-a6f0-45a8-837f-52b267417bd4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","rdfs:label":"Biancheri_3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032581.4(HYCC1):c.414+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339887"}},"firstTestingMethod":"PCR","phenotypeFreeText":"MRI findings: supratentorial hypomyelination, superimposed lesion in the PV region, high T2 signal of pyramidal tracts in mesencephalon and pons","phenotypes":["obo:HP_0001249","obo:HP_0006808","obo:HP_0007256","obo:HP_0002505"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/7e5062f3-67ef-486a-a1a7-70bc2ad22909_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7e5062f3-67ef-486a-a1a7-70bc2ad22909","type":"EvidenceLine","dc:description":"Founder/Recurrent variant. Per GCEP decision, not scoring multiple times","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e5062f3-67ef-486a-a1a7-70bc2ad22909_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/24c1556c-474b-40f0-b04e-6c278ddcc2ef_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24c1556c-474b-40f0-b04e-6c278ddcc2ef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","rdfs:label":"Biancheri_1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":23,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"firstTestingMethod":"PCR","phenotypeFreeText":"MRI findings: Supratentorial hypomyelination, Superimposed lesion in the PV region, high T2 signal of pyramidal tracts in mesencephalon","phenotypes":["obo:HP_0006808","obo:HP_0007256","obo:HP_0002505","obo:HP_0001249","obo:HP_0000519","obo:HP_0000639"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1278d6d7-0b16-49bd-806e-9c5ad90d8abe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/1278d6d7-0b16-49bd-806e-9c5ad90d8abe","type":"EvidenceLine","dc:description":"Founder/Recurrent variant. Per GCEP decision, not scoring multiple times","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1278d6d7-0b16-49bd-806e-9c5ad90d8abe_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7812bcd2-af3d-438a-9d68-4361b069ffa3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7812bcd2-af3d-438a-9d68-4361b069ffa3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","rdfs:label":"Biancheri_2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"firstTestingMethod":"PCR","phenotypeFreeText":"MRI findings:  supratentorial hypomyelination, superimposed lesion in the PV regions, mild cerebellar atrophy","phenotypes":["obo:HP_0002505","obo:HP_0006808","obo:HP_0001249","obo:HP_0007256","obo:HP_0001272","obo:HP_0000519","obo:HP_0000639"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fdf6a5b6-edf8-47ac-be01-706a14a6ea95_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/fdf6a5b6-edf8-47ac-be01-706a14a6ea95","type":"EvidenceLine","dc:description":"Founder/Recurrent variant. Per GCEP decision, not scoring multiple times","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fdf6a5b6-edf8-47ac-be01-706a14a6ea95_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0ff8dad9-0663-40b4-b2fa-c6ca1846ab1b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0ff8dad9-0663-40b4-b2fa-c6ca1846ab1b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23998934","rdfs:label":"Traverso_F1_P1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/557fb268-1eab-433b-832a-14a716bfbe5a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032581.4(HYCC1):c.100_101del (p.Lys34GlufsTer9)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658795133"}},"firstTestingMethod":"PCR","phenotypeFreeText":"Brain MRI showed diffuse supratentorial hypo-myelination with areas of more pronounced T1-hypointensity and T2-hyperintensity, consistent with increased water content in these regions","phenotypes":["obo:HP_0001249","obo:HP_0009830","obo:HP_0002650","obo:HP_0008936","obo:HP_0002505","obo:HP_0002061","obo:HP_0000486","obo:HP_0000639","obo:HP_0000519"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7b98673d-6a67-443f-beee-7909ee79d9eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23998934","allele":{"id":"https://genegraph.clinicalgenome.org/r/557fb268-1eab-433b-832a-14a716bfbe5a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/7b98673d-6a67-443f-beee-7909ee79d9eb","type":"EvidenceLine","dc:description":"Per ClinGen NDWG scoring guidelines, proband scores are capped at 2","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b98673d-6a67-443f-beee-7909ee79d9eb_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b6a4c2ea-4eb3-405d-a045-7e38f59aec89_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b6a4c2ea-4eb3-405d-a045-7e38f59aec89","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23998934","rdfs:label":"Traverso_F2_P3","ageType":"AgeAtReport","ageUnit":"Months","ageValue":14,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3cb02d04-f7f2-46b6-b229-af05d62eed4f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032581.4(HYCC1):c.169T>C (p.Cys57Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3336789"}},"firstTestingMethod":"PCR","phenotypeFreeText":"Brain MRI showed diffuse supratentorial hypomyelination","phenotypes":["obo:HP_0006808","obo:HP_0033257","obo:HP_0000519","obo:HP_0001252","obo:HP_0001348"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/28369641-9ccd-4531-950a-6a2aa8de8c89_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23998934","allele":{"id":"https://genegraph.clinicalgenome.org/r/3cb02d04-f7f2-46b6-b229-af05d62eed4f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/28369641-9ccd-4531-950a-6a2aa8de8c89","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28369641-9ccd-4531-950a-6a2aa8de8c89_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/28369641-9ccd-4531-950a-6a2aa8de8c89_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"40% reduction in Hyccin protein levels in patient fibroblasts compared to control","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5191a8a1-a410-4cbe-91e9-19698bb2f51d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23998934","rdfs:label":"Traverso_F2","family":{"id":"https://genegraph.clinicalgenome.org/r/5191a8a1-a410-4cbe-91e9-19698bb2f51d","type":"Family","rdfs:label":"Traverso_F2","member":{"id":"https://genegraph.clinicalgenome.org/r/b6a4c2ea-4eb3-405d-a045-7e38f59aec89"}},"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001252","obo:HP_0033257","obo:HP_0000519","obo:HP_0006808","obo:HP_0001348"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b6a4c2ea-4eb3-405d-a045-7e38f59aec89"}},{"id":"https://genegraph.clinicalgenome.org/r/0f51f634-92c9-4a29-b4ab-c267a484db2b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F3","estimatedLodScore":0.12,"family":{"id":"https://genegraph.clinicalgenome.org/r/0f51f634-92c9-4a29-b4ab-c267a484db2b","type":"Family","rdfs:label":"Zara_F3","member":{"id":"https://genegraph.clinicalgenome.org/r/17cfa125-61aa-450c-8b8a-b34f986ce089"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001317","obo:HP_0000519","obo:HP_0002505","obo:HP_0002650","obo:HP_0007256","obo:HP_0009830","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/17cfa125-61aa-450c-8b8a-b34f986ce089"},"publishedLodScore":1.67,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/2ebd8b0c-8734-40c9-913b-fcce7ff86ee7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F4","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/2ebd8b0c-8734-40c9-913b-fcce7ff86ee7","type":"Family","rdfs:label":"Zara_F4","member":{"id":"https://genegraph.clinicalgenome.org/r/093640e3-9383-498a-b732-dc6aff626d69","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F4_P7","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001317","obo:HP_0000519","obo:HP_0007305","obo:HP_0033044","obo:HP_0001249","obo:HP_0007256"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ae8e3189-07b6-4303-978a-8dc3f581f9cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0009830","obo:HP_0000519","obo:HP_0001249","obo:HP_0007256","obo:HP_0001317","obo:HP_0002505"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/093640e3-9383-498a-b732-dc6aff626d69"}},{"id":"https://genegraph.clinicalgenome.org/r/d2cae969-83a4-4a2a-a4dc-d29f8dffcb50_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F1","estimatedLodScore":3.31,"family":{"id":"https://genegraph.clinicalgenome.org/r/d2cae969-83a4-4a2a-a4dc-d29f8dffcb50","type":"Family","rdfs:label":"Zara_F1","member":{"id":"https://genegraph.clinicalgenome.org/r/43c763c3-e7e5-48e2-84dc-2c421d21d089","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F1_P1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/08eebf58-9ea8-4f96-946f-e3d5967662e5"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0007305","obo:HP_0009830","obo:HP_0007256","obo:HP_0000519","obo:HP_0001249"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0615317e-1e6d-4126-a366-fc078b17bab4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","allele":{"id":"https://genegraph.clinicalgenome.org/r/08eebf58-9ea8-4f96-946f-e3d5967662e5"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":12,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001249","obo:HP_0007256","obo:HP_0002505","obo:HP_0009830","obo:HP_0000519"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/43c763c3-e7e5-48e2-84dc-2c421d21d089"}},{"id":"https://genegraph.clinicalgenome.org/r/b13ea5b8-290c-46bd-bf62-487908575bdc_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17928815","rdfs:label":"Ugur_F1","estimatedLodScore":1.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/b13ea5b8-290c-46bd-bf62-487908575bdc","type":"Family","rdfs:label":"Ugur_F1","member":{"id":"https://genegraph.clinicalgenome.org/r/26accb24-05e6-4702-81d2-e4e57f804ffb"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001250","obo:HP_0000519","obo:HP_0002505","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/26accb24-05e6-4702-81d2-e4e57f804ffb"},"publishedLodScore":4.41,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ac70e096-2de3-4194-a812-3896956f219a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F2","family":{"id":"https://genegraph.clinicalgenome.org/r/ac70e096-2de3-4194-a812-3896956f219a","type":"Family","rdfs:label":"Zara_F2","member":{"id":"https://genegraph.clinicalgenome.org/r/d7622b8c-ff2a-4141-ae8a-4359370737b5"}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000519","obo:HP_0001250","obo:HP_0002505","obo:HP_0002650","obo:HP_0001317","obo:HP_0007256","obo:HP_0009830","obo:HP_0001249"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/d7622b8c-ff2a-4141-ae8a-4359370737b5"},"publishedLodScore":1.2,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b60a0a11-3427-4241-bc29-6863d3a0ab18_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23998934","rdfs:label":"Traverso_F1","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/b60a0a11-3427-4241-bc29-6863d3a0ab18","type":"Family","rdfs:label":"Traverso_F1","member":{"id":"https://genegraph.clinicalgenome.org/r/0ff8dad9-0663-40b4-b2fa-c6ca1846ab1b"}},"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002505","obo:HP_0000486","obo:HP_0008936","obo:HP_0002650","obo:HP_0000519","obo:HP_0009830","obo:HP_0001249","obo:HP_0002061","obo:HP_0000639"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0ff8dad9-0663-40b4-b2fa-c6ca1846ab1b"}},{"id":"https://genegraph.clinicalgenome.org/r/8c7d9450-180c-4456-85d9-b32f94772ac1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F5","estimatedLodScore":0.25,"family":{"id":"https://genegraph.clinicalgenome.org/r/8c7d9450-180c-4456-85d9-b32f94772ac1","type":"Family","rdfs:label":"Zara_F5","member":{"id":"https://genegraph.clinicalgenome.org/r/48fdc916-20b3-42e2-9edf-205060fd6fbc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","rdfs:label":"Zara_F5_P10","ageType":"AgeAtReport","ageUnit":"Years","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e1287faa-8ced-4f51-ba81-cf948682d324","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032581.4(HYCC1):c.158T>C (p.Leu53Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA339888"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001249","obo:HP_0007256","obo:HP_0000519"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/896632cf-7859-49c0-acbc-1fcb1b828649_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16951682","allele":{"id":"https://genegraph.clinicalgenome.org/r/e1287faa-8ced-4f51-ba81-cf948682d324"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0001249","obo:HP_0007256","obo:HP_0000519"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/48fdc916-20b3-42e2-9edf-205060fd6fbc"},"publishedLodScore":1.67,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/92c2e221-81c3-4993-80e4-cce82174d15f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/92c2e221-81c3-4993-80e4-cce82174d15f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","rdfs:label":"Biancheri_5","ageType":"AgeAtReport","ageUnit":"Years","ageValue":15,"allele":{"id":"https://genegraph.clinicalgenome.org/r/51ed01bb-ed08-4386-b8d0-0f7327f942f9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032581.4(HYCC1):c.215_224dup (p.Leu76SerfsTer25)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695207523"}},"firstTestingMethod":"PCR","phenotypeFreeText":"MRI findings: supratentorial hypomyelination, Superimposed lesion in the PV regions high T2 signal of pyramidal tracts in mesencephalon and pons","phenotypes":["obo:HP_0007256","obo:HP_0001249","obo:HP_0000519","obo:HP_0000639","obo:HP_0002505","obo:HP_0006808"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/76bde3bb-2a3d-4589-816b-9a5a3eb8e3d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","allele":{"id":"https://genegraph.clinicalgenome.org/r/51ed01bb-ed08-4386-b8d0-0f7327f942f9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/76bde3bb-2a3d-4589-816b-9a5a3eb8e3d7","type":"EvidenceLine","dc:description":"Per ClinGen NDWG scoring guidelines, proband scores are capped at 2 pts","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76bde3bb-2a3d-4589-816b-9a5a3eb8e3d7_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/093640e3-9383-498a-b732-dc6aff626d69_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/093640e3-9383-498a-b732-dc6aff626d69"},{"id":"https://genegraph.clinicalgenome.org/r/ae8e3189-07b6-4303-978a-8dc3f581f9cb","type":"EvidenceLine","dc:description":"Per ClinGen NDWG scoring guidelines, proband scores are capped at 2","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae8e3189-07b6-4303-978a-8dc3f581f9cb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ae8e3189-07b6-4303-978a-8dc3f581f9cb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Absent protein expression in patient fibroblasts ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/94466d38-6b00-448a-95cf-76c497278ef0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94466d38-6b00-448a-95cf-76c497278ef0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","rdfs:label":"Biancheri_4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000519","obo:HP_0006808","obo:HP_0002505","obo:HP_0001249","obo:HP_0000639","obo:HP_0007256","obo:HP_0001317"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f3753171-ac5b-49e2-a410-9a33d6e871c6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","allele":{"id":"https://genegraph.clinicalgenome.org/r/2bb52c12-fa7e-40eb-be57-e74b89dea047"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/f3753171-ac5b-49e2-a410-9a33d6e871c6","type":"EvidenceLine","dc:description":"Founder/Recurrent variant. Per GCEP decision, not scoring multiple times","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3753171-ac5b-49e2-a410-9a33d6e871c6_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/48fdc916-20b3-42e2-9edf-205060fd6fbc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48fdc916-20b3-42e2-9edf-205060fd6fbc"},{"id":"https://genegraph.clinicalgenome.org/r/896632cf-7859-49c0-acbc-1fcb1b828649","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/896632cf-7859-49c0-acbc-1fcb1b828649_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/896632cf-7859-49c0-acbc-1fcb1b828649_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced protein expression in patient fibroblasts. Miyamoto 2014 (PMID:24417797) also found that the p.Leu53Pro mutant protein aggregated within the ER membrane and Golgi apparatus instead of entering plasma membrane.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0d1a4538-4ebd-433c-82c8-dfc00c242de0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d1a4538-4ebd-433c-82c8-dfc00c242de0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","rdfs:label":"Biancheri_6","ageType":"AgeAtReport","ageUnit":"Years","ageValue":18,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1ce08fce-1f06-4c36-bf04-75c7b8330392","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_032581.4(HYCC1):c.274del (p.Ser92AlafsTer15)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695207522"}},"firstTestingMethod":"PCR","phenotypeFreeText":"MRI findings: supratentorial hypomyelination, superimposed lesions in the PV regions, high T2 signal of pyramidal tracts in mesencephalon and pons (improved with age)","phenotypes":["obo:HP_0001250","obo:HP_0001249","obo:HP_0000519","obo:HP_0001317","obo:HP_0002505","obo:HP_0007256","obo:HP_0006808"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/6c8b7380-301c-4c27-ba33-ff1666412e9f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21911699","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ce08fce-1f06-4c36-bf04-75c7b8330392"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/6c8b7380-301c-4c27-ba33-ff1666412e9f","type":"EvidenceLine","dc:description":"Per ClinGen NDWG scoring guidelines, proband scores are capped at 2 pts","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c8b7380-301c-4c27-ba33-ff1666412e9f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/43c763c3-e7e5-48e2-84dc-2c421d21d089_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43c763c3-e7e5-48e2-84dc-2c421d21d089"},{"id":"https://genegraph.clinicalgenome.org/r/0615317e-1e6d-4126-a366-fc078b17bab4","type":"EvidenceLine","dc:description":"Founder/Recurrent variant. per GCEP decision, not scoring multiple times","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0615317e-1e6d-4126-a366-fc078b17bab4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/0615317e-1e6d-4126-a366-fc078b17bab4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Absent expression of protein in patient fibroblasts","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d38cc2b1-8d36-434a-825d-b68162fb0c2d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44d406ec-93a6-49c3-976e-e41571f4f9c5","type":"Finding","dc:description":"LacZ regulatory elements were integrated into the HYCC1 locus of heterozygous Hyccin mice, allowing the tissue location of Hyccin to be studied by LacZ staining. Hyccin gene expression was then found in olfactory nuclei, distinct layers of the neocortex, and hippocampal regions","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22461884","rdfs:label":"Gazzerro_expression_study","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1717e62b-6b1e-47fd-a335-de3fd597f7a4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f95f393c-9f27-4cb6-98d2-02f03d157e0f","type":"EvidenceLine","dc:description":"Because the model is non-mammalian, but all phenotypic aspects were rescued, the GCEP decided to downgrade the score to 1 pt. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6426c445-b6eb-4da0-9919-ff2903a058ba","type":"Finding","dc:description":"Normal glial cell development and myelination. Normal visual system as shown in phototaxis assay","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34894559","rdfs:label":"Zhang_Drosophila_rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/40a00c2c-763a-45fc-96b2-f7277808ea8f","type":"EvidenceLine","dc:description":"Because model organism is non-mammalian but the phenotype displayed is still relatively specific, the GCEP decided to downgrade the score for this experimental evidence to 1 pt.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b23d887e-4bc1-4c2b-a009-a5d7deffe332","type":"Finding","dc:description":"Transgenic Hyccin knockdown Drosophila were created, and demonstrated loss of glial cells and photorecepter cells, disrupted columnar architecture and compartmentalization of the optic lobes in the visual system, and a loss of the columnar medulla glia. CD8-RFP labeling showed remarkably decreased Hyccin expression in the visual system. Loss of glial cell bodies and visual system alterations were rescued by the expression of human FAM126A, which demonstrated that Hyccin is essential for enrichment of glial and axonal sheath formation. Flies also had reduced visual ability (based on phototaxis assay) but not climbing ability compared to wildtype. Phenotypes oberved in model system (loss of Glial cells, disruption of visual system, loss of columnar medulla glia, and impaired visual ability) is similar to CNS disruption observed in affected individuals.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34894559","rdfs:label":"Zhang_Drosphila_model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5}],"evidenceStrength":"Definitive","sequence":10065,"specifiedBy":"GeneValidityCriteria11","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/29sqe1jwJHU","type":"GeneValidityProposition","disease":"obo:MONDO_0012514","gene":"hgnc:24587","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1717e62b-6b1e-47fd-a335-de3fd597f7a4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}